These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9343327)

  • 1. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
    Koss LG; Lin E; Schreiber K; Elgert P; Mango L
    Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
    Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
    Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.
    Sherman ME; Mango LJ; Kelly D; Paull G; Ludin V; Copeland C; Solomon D; Schiffman MH
    Mod Pathol; 1994 Jun; 7(5):578-81. PubMed ID: 7937724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection.
    Ronnett BM; Manos MM; Ransley JE; Fetterman BJ; Kinney WK; Hurley LB; Ngai JS; Kurman RJ; Sherman ME
    Hum Pathol; 1999 Jul; 30(7):816-25. PubMed ID: 10414501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
    Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing spectrum of squamous cell abnormalities observed on papanicolaou smears in Mubarak Al-Kabeer Hospital, Kuwait, over a 13-year period.
    Kapila K; George SS; Al-Shaheen A; Al-Ottibi MS; Pathan SK; Sheikh ZA; Haji BE; Mallik MK; Das DK; Francis IM
    Med Princ Pract; 2006; 15(4):253-9. PubMed ID: 16763390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAPNET computer-aided rescreening for detection of benign and malignant glandular elements in cervicovaginal smears: a review of 61 cases.
    Sturgis CD; Isoe C; McNeal NE; Yu GH; DeFrias DV
    Diagn Cytopathol; 1998 Apr; 18(4):307-11. PubMed ID: 9557269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papnet-assisted, primary screening of cervico-vaginal smears.
    Duggan MA
    Eur J Gynaecol Oncol; 2000; 21(1):35-42. PubMed ID: 10726616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.